Dr Christos Mikropoulos

  • MBBS, MSc, MD (Res), MRCP, FRCR
  • Clinical oncologist
  • Spoken languages English

Overview

Awards recieved

  • Merit Award GU ASCO 2014 for Poster Presentation on ‘PROFILE: Results of a pilot study on targeted prostate cancer screen for men with family history of prostate cancer’.
  • 2014 Ross RCR Poster Award for ‘The prevalence of the HOXB13 mutation in UK men and correlation with phenotype and outcomes’.
  • Merit Award GU ASCO 2015 for the Poster Presentation on ‘The IMPACT study: Identification of Men with a genetic predisposition to ProstAte Cancer: Targeted screening in men at higher genetic risk and controls: Prostate-Specific Antigen Velocity as a predictive biomarker in a prospective Prostate Cancer Screening Study of Men with genetic predisposition.’

Professional affiliation

  • Member of the Royal College of Physicians (MRCP)
  • Fellow of the Royal College of Radiologists (FRCP)
  • Member of the European Society of Medical Oncology (ESMO)
  • Member of the European Society of Therapeutic Radiation Oncology (ESTRO)

Clinical interests

  • Co-investigator and developer of the GENPROS study, which is a non-interventional study that will collect clinical outcome data for men diagnosed with prostate cancer with a known germline genetic predisposition.
  • Co-investigator and developer of the GENPET study, which is an imaging single arm study assessing the sensitivity of F-Choline-PET to detect nodal metastases in men with a germline BRCA mutation.
  • Co-investigator and developer of the BARCODE-1 study – a prostate cancer screening study which will genetically profile 5000 men and identify the top 10% men at most genetic risk and offer them a diagnostic prostatic biopsy.